Cardiorenal Protection

Use of Renin-Angiotensin System Inhibitors in Patients with CKDStage 4 and 5: What to Do and What Not to Do

by Prateek Chopra | June 18, 2026 | Cardiology Conferences | ESH 2026 Clinical Rationale: RAS inhibitors (RASi) reduce CKD progression and cardiovascular risk but are frequently discontinued in patients with eGFR <30 ml/min/1.73m² due to concerns about hyperkalemia, hypotension, and renal function deterioration. Evidence Review: Management of Hyperkalemia: Consequences of RASi Discontinuation: Clinical Implications: In patients with CKD G4–G5, RASi […]

Use of Renin-Angiotensin System Inhibitors in Patients with CKDStage 4 and 5: What to Do and What Not to Do Read Post »

Leave a Comment / ESH Day 4 / / / , , , ,

New Therapies in the Prevention of Cardiac Damage in Patientswith CKM Syndrome

by Prateek Chopra | June 3, 2026 | Cardiology Conferences | ESH 2026 Clinical Context: Cardiovascular-kidney-metabolic (CKM) syndrome encompasses overlapping progression of cardiovascular disease, chronic kidney disease, obesity, diabetes, and hypertension, resulting in persistent myocardial injury and increased heart failure risk. Contemporary management focuses on integrated therapies targeting cardio-renal-metabolic pathways to prevent progressive cardiac damage. Key Pathophysiology & Mechanisms: Emerging Therapeutic

New Therapies in the Prevention of Cardiac Damage in Patientswith CKM Syndrome Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,

Disparities in Sodium–Glucose Cotransporter Inhibitor Use: A Systematic Literature Review

by Prateek Chopra | June 27, 2026 | Diabetes Conferences | ADA 2026 Clinical Objective Methods Study Selection Key Findings Potential Contributors to Disparities Clinical Implications Evidence from this systematic review indicates persistent sociodemographic disparities in SGLT2 inhibitor utilization across the United States. Further research is needed to better understand the drivers of these inequities and develop strategies to improve

Disparities in Sodium–Glucose Cotransporter Inhibitor Use: A Systematic Literature Review Read Post »

Leave a Comment / Diabetes Conferences / / / , , , , ,
Scroll to Top